• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体 γ 介导合成大麻素 WIN55,212-2 对人肝癌 BEL-7402 细胞增殖和凋亡的影响。

PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.

机构信息

Department of Biochemistry, Guangzhou Medical University, Guangzhou, 510182, China.

出版信息

Mol Biol Rep. 2013 Nov;40(11):6287-93. doi: 10.1007/s11033-013-2741-x. Epub 2013 Sep 24.

DOI:10.1007/s11033-013-2741-x
PMID:24062073
Abstract

Cannabis sativa has long been used as a traditional medicine in China. Among its effective compounds are cannabinoids. This study determined the effect of WIN55,212-2 (WIN), a synthetic cannabinoid, on the BEL-7402 human hepatocellular carcinoma (HCC) cell line. The results showed that WIN could decrease the proliferation of BEL-7402 cells. Moreover, WIN could cause apoptosis of the cells via up-regulation of Bax expression, down-regulation of Bcl-2 expression, induction of the mitochondrial membrane potential, increase of caspase-3, -8 and -9 activities, and induction of the cleavage of caspase-3 and poly-ADP-ribose polymerase (PARP). The WIN-induced apoptosis was accompanied by the up-regulation of PPARγ expression, the activation of PPARγ DNA binding activity, and a down-regulation of PPARγ target oncogene c-myc. Conversely, the effects of WIN could be attenuated by PPARγ antagonist GW9662, and the WIN induced PPARγ expression was partially attenuated by AM630, a cannabinoid receptor-2 antagonist, whereas the WIN-induced reduction of c-myc expression was partially restored by GW9662. Collectively, our results suggest that WIN can decrease the proliferation and cause apoptosis of the BEL-7402 cells via a mitochondrial-caspase pathway and mediated by PPARγ. These results may provide a basis for the application of WIN in HCC treatment.

摘要

大麻长期以来一直被用作中国的传统药物。其有效成分之一是大麻素。本研究旨在确定合成大麻素 WIN55,212-2(WIN)对 BEL-7402 人肝癌(HCC)细胞系的影响。结果表明,WIN 可降低 BEL-7402 细胞的增殖。此外,WIN 通过上调 Bax 表达、下调 Bcl-2 表达、诱导线粒体膜电位、增加 caspase-3、-8 和 -9 活性以及诱导 caspase-3 和多聚 ADP-核糖聚合酶(PARP)的切割,诱导细胞凋亡。WIN 诱导的细胞凋亡伴随着 PPARγ 表达的上调、PPARγ DNA 结合活性的激活以及 PPARγ 靶癌基因 c-myc 的下调。相反,PPARγ 拮抗剂 GW9662 可减弱 WIN 的作用,大麻素受体-2 拮抗剂 AM630 部分减弱 WIN 诱导的 PPARγ 表达,而 GW9662 部分恢复 WIN 诱导的 c-myc 表达降低。总之,我们的研究结果表明,WIN 可通过线粒体 caspase 途径和 PPARγ 介导,降低 BEL-7402 细胞的增殖并诱导其凋亡。这些结果可能为 WIN 在 HCC 治疗中的应用提供依据。

相似文献

1
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.过氧化物酶体增殖物激活受体 γ 介导合成大麻素 WIN55,212-2 对人肝癌 BEL-7402 细胞增殖和凋亡的影响。
Mol Biol Rep. 2013 Nov;40(11):6287-93. doi: 10.1007/s11033-013-2741-x. Epub 2013 Sep 24.
2
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.合成大麻素WIN诱导HepG2细胞凋亡:转录因子PPARγ的作用
Biochimie. 2009 Apr;91(4):457-65. doi: 10.1016/j.biochi.2008.11.003. Epub 2008 Nov 27.
3
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.合成大麻素 WIN 55,212-2 通过激活 p8/CCAAT/增强子结合蛋白同源蛋白 (CHOP)/死亡受体 5 (DR5) 轴使肝癌细胞对肿瘤坏死因子相关凋亡诱导配体 (TRAIL) 诱导的细胞凋亡敏感。
Mol Pharmacol. 2010 May;77(5):854-63. doi: 10.1124/mol.109.062257. Epub 2010 Feb 16.
4
WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.WIN 通过依赖于 PPARγ 下调的自噬流阻滞诱导人结肠癌细胞发生凋亡性细胞死亡。
Apoptosis. 2014 Jun;19(6):1029-42. doi: 10.1007/s10495-014-0985-0.
5
The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.CB1/CB2受体激动剂WIN-55,212-2在体外可降低人卡波西肉瘤细胞的活力。
Eur J Pharmacol. 2009 Aug 15;616(1-3):16-21. doi: 10.1016/j.ejphar.2009.06.004. Epub 2009 Jun 17.
6
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.大麻素在前列腺癌和结肠癌细胞中诱导细胞凋亡依赖于磷酸酶。
Anticancer Res. 2011 Nov;31(11):3799-807.
7
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.大麻素WIN55,212-2可诱导细胞周期停滞,并抑制人BEL7402肝癌细胞的增殖和迁移。
Mol Med Rep. 2015 Dec;12(6):7963-70. doi: 10.3892/mmr.2015.4477. Epub 2015 Oct 23.
8
[Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells].[大麻素WIN55,212-2抑制人SMMC-7721肝癌细胞的增殖、侵袭和迁移]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 May;32(5):619-24.
9
[The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].大麻素受体激活对肝癌HepG2细胞增殖和凋亡的影响
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Apr;26(4):344-7.
10
Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.PPAR-γ 在大麻素受体激动剂 WIN55,212-2 诱导和表达行为敏化中的双重作用。
Neuromolecular Med. 2013 Sep;15(3):523-35. doi: 10.1007/s12017-013-8238-x. Epub 2013 Jun 21.

引用本文的文献

1
Cannabidiol (CBD) as a potential therapeutic agent for liver cancer: a comprehensive review of current evidence.大麻二酚(CBD)作为肝癌的潜在治疗药物:当前证据的综合综述
Cancer Cell Int. 2025 Jun 18;25(1):215. doi: 10.1186/s12935-025-03870-3.
2
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System.过氧化物酶体增殖物激活受体在与内源性大麻素系统相关的多靶点范式中的相关性。
Int J Mol Sci. 2021 Jan 20;22(3):1001. doi: 10.3390/ijms22031001.
3
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy.

本文引用的文献

1
Cannabinoid-associated cell death mechanisms in tumor models (review).大麻素相关的肿瘤模型中的细胞死亡机制(综述)。
Int J Oncol. 2012 Aug;41(2):407-13. doi: 10.3892/ijo.2012.1476. Epub 2012 May 14.
2
Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.中国的乙型肝炎和丙型肝炎病毒感染与肝细胞癌:流行病学和控制措施综述。
J Epidemiol. 2011;21(6):401-16. doi: 10.2188/jea.je20100190. Epub 2011 Oct 22.
3
Cannabinoids, endocannabinoids, and cancer.大麻素、内源性大麻素与癌症。
调节内源性大麻素系统作为一种潜在的抗癌策略。
Front Pharmacol. 2019 May 9;10:430. doi: 10.3389/fphar.2019.00430. eCollection 2019.
4
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance.内源性大麻素系统作为肿瘤细胞恶性程度的调节因子——生物学途径及临床意义
Onco Targets Ther. 2016 Jul 18;9:4323-36. doi: 10.2147/OTT.S106944. eCollection 2016.
5
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.合成大麻素WIN55,212-2甲磺酸盐通过激活CB2、TRPV1、TRPA1以及尚未明确的受体靶点,降低类风湿性关节炎滑膜成纤维细胞中炎症介质的产生。
J Inflamm (Lond). 2016 May 5;13:15. doi: 10.1186/s12950-016-0114-7. eCollection 2016.
6
An update on PPAR activation by cannabinoids.大麻素对过氧化物酶体增殖物激活受体(PPAR)激活作用的最新进展。
Br J Pharmacol. 2016 Jun;173(12):1899-910. doi: 10.1111/bph.13497. Epub 2016 May 19.
7
Autophagy regulation in the development and treatment of breast cancer.自噬调节在乳腺癌的发生发展及治疗中的作用
Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):60-74. doi: 10.1093/abbs/gmv119. Epub 2015 Dec 5.
8
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.大麻素WIN55,212-2可诱导细胞周期停滞,并抑制人BEL7402肝癌细胞的增殖和迁移。
Mol Med Rep. 2015 Dec;12(6):7963-70. doi: 10.3892/mmr.2015.4477. Epub 2015 Oct 23.
Cancer Metastasis Rev. 2011 Dec;30(3-4):599-612. doi: 10.1007/s10555-011-9318-8.
4
The intersection between cannabis and cancer in the United States.美国的大麻与癌症的交集。
Crit Rev Oncol Hematol. 2012 Jul;83(1):1-10. doi: 10.1016/j.critrevonc.2011.09.008. Epub 2011 Oct 21.
5
Systematic review of hepatocellular adenoma in China and other regions.中国及其他地区肝细胞腺瘤的系统评价。
J Gastroenterol Hepatol. 2011 Jan;26(1):28-35. doi: 10.1111/j.1440-1746.2010.06502.x.
6
[The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].大麻素受体激活对肝癌HepG2细胞增殖和凋亡的影响
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Apr;26(4):344-7.
7
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.合成大麻素受体激动剂和拮抗剂的受体和通道。
Curr Med Chem. 2010;17(14):1360-81. doi: 10.2174/092986710790980050.
8
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.合成大麻素WIN诱导HepG2细胞凋亡:转录因子PPARγ的作用
Biochimie. 2009 Apr;91(4):457-65. doi: 10.1016/j.biochi.2008.11.003. Epub 2008 Nov 27.
9
Modulation of the endocannabinoid system by lipid rafts.脂筏对内源性大麻素系统的调节作用。
Curr Med Chem. 2007;14(25):2702-15. doi: 10.2174/092986707782023235.
10
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.大麻素受体CB1和CB2的过表达与肝细胞癌患者预后改善相关。
Cancer Genet Cytogenet. 2006 Nov;171(1):31-8. doi: 10.1016/j.cancergencyto.2006.06.014.